Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
HEALTH AND HUMAN SERVICES, DEPARTMENT OF | FOOD AND DRUG ADMINISTRATION has floated a tender for Sources Sought Notice FDA Office of Clinical Pharmacology (OCP)/Division of Applied Regulatory Science (DARS) Purchase of Phenomenex High-Pressure Liquid Chromatography (HPLC) Core-Shell Technology Co.... The project location is USA and the tender is closing on 01 Jul 2025. The tender notice number is CDER-OTS-25-C-1691, while the TOT Ref Number is 121525073. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : USA
Summary : Sources Sought Notice FDA Office of Clinical Pharmacology (OCP)/Division of Applied Regulatory Science (DARS) Purchase of Phenomenex High-Pressure Liquid Chromatography (HPLC) Core-Shell Technology Co...
Deadline : 01 Jul 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 121525073
Document Ref. No. : CDER-OTS-25-C-1691
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Sources Sought Notice FDA Office of Clinical Pharmacology (OCP)/Division of Applied Regulatory Science (DARS) Purchase of Phenomenex High-Pressure Liquid Chromatography (HPLC) Core-Shell Technology Columns and Consumables
Description
The Food and Drug Administration (FDA) is seeking to purchase critical supplies neccesary for the Division of Applied Regulatory Science (DARS) bioanalytical lab to continue supporting mission- critical research focused on review questions, translational science, and emerging public health issues for the Center for Drug Evaluation and Research (CDER) and FDA. DARS operates six total labs that focus on developing and evaluating novel tools, standards, and approaches that increase the regulatory efficiency of developing and reviewing safe and effective CDER products. These operational supplies are essential for the continuance of these projects across all lab groups, and for continued preparedness to be able to respond to emergent public health issues when called upon.
We kindly request that each interested vendor also complete and submit the attached vendor feedback form along with a capability statement for consideration.
Active Contract Opportunity
Notice ID : CDER-OTS-25-C-1691
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : FOOD AND DRUG ADMINISTRATION
Office: FDA OFFICE OF ACQ GRANT SVCS
General Information
Contract Opportunity Type: Sources Sought (Original)
Original Published Date: Jun 24, 2025 12:42 pm EDT
Original Response Date: Jul 01, 2025 05:00 am EDT
Inactive Policy: 15 days after response date
Original Inactive Date: Jul 16, 2025
Initiative: None
Classification
Original Set Aside: Total Small Business Set-Aside (FAR 19.5)
Product Service Code: AJ12 - GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH
NAICS Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Place of Performance: Silver Spring, MD USA
Documents
Draft-Statement-of-Work-CDER-2025-128753.docx
Procurement Documents for USA
Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA
Want To Bid in This Tender?
Get Local Agent Support in USA and 60 More Countries.
View Tenders By
Sign in with Google